Purpose
The aim of the present study was to investigate the role of intestinal first-pass metabolism of baicalein (B) in its absorption process.
Methods
The intestinal absorption of B was characterized using Caco-2 cell monolayer model and rat in situ single-pass intestinal perfusion model. In addition, preliminary metabolic kinetics of B was evaluated in both rat and human intestinal S9 fractions.
Results
B was well absorbed and extensively metabolized to baicalin (BG), baicalein-7-O-β-glucuronide, in rat intestinal perfusion model, whereas less extent of metabolism was observed in the Caco-2 cell monolayer model. Moreover, BG generated in the intestinal epithelium during the absorption of B also rapidly transported to both the apical side (the apical chamber of Caco-2 model and the perfusate of the intestinal perfusion model) as well as the basolateral side of the small intestine (the basal chamber of Caco-2 model and the mesenteric vein of the intestinal perfusion model). From the preliminary metabolic studies, it was found that a higher loading dose of B resulted in a less extent of metabolism in intestine. In addition, the extent of metabolism of B was similar in jejunum and ileum when 50 μM of B was perfused through different sections of rat small intestine.
Conclusion
The first-pass metabolism of B in small intestine may play an important role in its low oral bioavailability.
Similar content being viewed by others
References
D. Yang H. Hu S. Huang J. P. Chaumont J. Millet (2000) ArticleTitleStudy on the inhibitory activity, in vitro, of baicalein and baicalin against skin fungi and bacteria Zhongyaocai 23 272–274
C. J. Chen S. L. Raung S. L. Liao S. Y. Chen (2004) ArticleTitleInhibition of inducible nitric oxide synthase expression by baicalein in endotoxin/cytokine-stimulated microglia Biochem. Pharmacol. 5 957–965
T. Hong G. B. Jin S. Cho J. C. Cyong (2002) ArticleTitleEvaluation of the anti-inflammatory effect of baicalein on dextran sulfate sodium-induced colitis in mice Planta Med. 68 268–271
M. Kimata M. Shichijo T. Miura I. Serizawa N. Inagaki H. Nagai (2000) ArticleTitleEffects of luteolin, quercetin and baicalein on immunoglobulin E-mediated mediator release from human cultured mast cells Clin. Exp. Allergy 30 501–508
Z. H. Shao T. L. Hoek ParticleVanden Y. Qin L. B. Becker P. T. Schumacker C. Q. Li L. Dey E. Barth H. Halpern G. M. Rosen C. S. Yuan (2002) ArticleTitleBaicalein attenuates oxidant stress in cardiomyocytes Am. J. Physiol. 282 H999–H1006
K. Ono H. Nakane (1990) ArticleTitleMechanisms of inhibition of various cellular DNA and RNA polymerases by several flavonoids J. Biochem. 108 609–613
B. H. Lee S. J. Lee T. H. Kang D. H. Kim D. H. Sohn G. Ko Y. C. Kim (2000) ArticleTitleBaicalein, an in vitro antigenotoxic compound from Scutellaria baicalensis Planta Med. 66 70–71
T. Akao K. Kawabata E. Yanagisawa K. Ishihara Y. Mizuhara Y. Wakui Y. Sakashita K. Kobashi (2000) ArticleTitleBaicalin, the predominant flavone glucuronide of scutellariae radix, is absorbed from the rat gastrointestinal tract as the aglycone and restored to its original form J. Pharm. Pharmacol. 52 1563–1568
M. Y. Lai S. L. Hsiu S. Y. Tsai Y. C. Hou P. D. Chao (2003) ArticleTitleComparison of metabolic pharmacokinetics of baicalin and baicalein in rats J. Pharm. Pharmacol. 55 205–209
M. Y. Lai S. L. Hsiu C. C. Chen Y. C. Hou P. D. Chao (2003) ArticleTitleUrinary pharmacokinetics of baicalein, wogonin and their glycosides after oral administration of scutellariae radix in humans Biol. Pharm. Bull. 26 79–83
J. Chen H. Lin M. Hu (2003) ArticleTitleMetabolism of flavonoids via enteric recycling: role of intestinal disposition J. Pharmacol. Exp. Ther. 304 1228–1235
M. Hu J. Chen H. Lin (2003) ArticleTitleMetabolism of flavonoids via enteric recycling: mechanistic studies of disposition of apigenin in the Caco-2 cell culture model J. Pharmacol. Exp. Ther. 307 314–321
U. K. Walle A. Galijatovic T. Walle (1999) ArticleTitleTransport of the flavonoid chrysin and its conjugated metabolites by the human intestinal cell line Caco-2 Biochem. Pharmacol. 58 431–438
D. Sun H. Lennernas L. S. Welage J. L. Barnett C. P. Landowski D. Foster D. Fleisher K. D. Lee G. L. Amidon (2002) ArticleTitleComparison of human duodenum and Caco-2 gene expression profiles for 12,000 gene sequences tags and correlation with permeability of 26 drugs Pharm. Res. 19 1400–1416
Y. Liu M. Hu (2002) ArticleTitleAbsorption and metabolism of flavonoids in the Caco-2 cell culture model and a perused rat intestinal model Drug Metab. Dispos. 30 370–377
L. Zhang Y. Zheng M. Chow Z. Zuo (2004) ArticleTitleInvestigation of intestinal absorption and disposition of green tea catechins by Caco-2 monolayer model Int. J. Pharm. 287 1–12
L. Zhang G. Lin Z. Zuo (2004) ArticleTitleHigh-performance liquid chromatographic method for simultaneous determination of baicalein and baicalein 7-glucuronide in rat plasma J. Pharm. Biomed. Anal. 36 637–641
D. E. Williams R. L. Reed B. Kedzierski G. A. Dannan F. P. Guengerich D. R. Buhler (1989) ArticleTitleBioactivation and detoxication of the pyrrolizidine alkaloid senecionine by cytochrome P-450 enzymes in rat liver Drug Metab. Dispos. 17 387–392
P. Artursson J. Karlsson (1991) ArticleTitleCorrelation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells Biochem. Biophys. Res. Commun. 175 880–885
N. Okudaira T. Tatebayashi G. C. Speirs I. Komiya Y. Sugiyama (2000) ArticleTitleA study of the intestinal absorption of an ester-type prodrug, ME3229, in rats: active efflux transport as a cause of poor bioavailability of the active drug J. Pharmacol. Exp. Ther. 294 580–587
G. L. Amidon G. D. Leesman R. L. Elliott (1980) ArticleTitleImproving intestinal absorption of water-insoluble compounds: a membrane metabolism strategy J. Pharm. Sci. 69 1363–1368
B. M. Johnson W. Q. Chen R. T. Borchardt W. N. Charman C. H. Porter (2003) ArticleTitleA kinetic evaluation of the absorption, efflux, and metabolism of verapamil in the autoperfused rat jejunum J. Pharmacol. Exp. Ther. 305 151–158
C. L. Cummins L. Salphati M. J. Reid L. Z. Benet (2003) ArticleTitleIn vivo modulation of intestinal CYP3A metabolism by P-glycoprotein: studies using the rat single-pass intestinal perfusion model J.Pharmacol. Exp. Ther. 305 306–314
S. Yee (1997) ArticleTitleIn vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man—fact or myth Pharm. Res. 14 763–766
Y. Wang R. Aun F. L. Tse (1997) ArticleTitleAbsorption of d-glucose in the rat studied using in situ intestinal perfusion: a permeability-index approach Pharm. Res. 14 1563–1567
A. J. Day M. S. DuPont S. Ridley M. Rhodes M. J. Rhodes M. R. Morgan G. Williamson (1998) ArticleTitleDeglycosylation of flavonoid and isoflavonoid glycosides by human small intestine and liver beta-glucosidase activity FEBS Lett. 436 71–75
A. J. Day F. J. Canada J. C. Diaz P. A. Kroon R. Mclauchlan C. B. Faulds G. W. Plumb M. R. Morgan G. Williamson (2000) ArticleTitleDietary flavonoid and isoflavone glycosides are hydrolysed by the lactase site of lactase phlorizin hydrolase FEBS Lett. 468 166–170
P. Borst R. Evers M. Kool J. Wijnholds (2000) ArticleTitleA family of drug transporters: the multidrug resistance-associated proteins J. Natl. Cancer Inst. 92 1295–1302
K. S. Pang (2003) ArticleTitleModeling of intestinal drug absorption: roles of transporters and metabolic enzymes Drug Metab. Dispos. 31 1507–1519
N. W. Baylor T. Fu Y. D. Yan F. W. Ruscetti (1992) ArticleTitleInhibition T cell leukemia virus by the plant flavonoid baicalin (7-glucuronic acid, 5,6-dihydroxyflavone) J. Infect. Dis. 165 433–437
W. H. Chang C. H. Chen F. J. Lu (2000) ArticleTitleDifferent effects of baicalein, baicalin and wogonin on mitochondrial function, glutathione content and cell cycle progression in human hepatoma cell lines Planta Med. 68 128–132
S. Chen Q. Ruan E. Bedner A. Deptala X. Wang T. C. Hsieh F. Traganos Z Darzynkiewicz (2001) ArticleTitleEffects of the flavonoid baicalin and its metabolite baicalein on androgen receptor expression, cell cycle progression and apoptosis of prostate cancer cell lines Cell Prolif. 34 293–304
S. Ikemoto K Sugimura N. Yoshida R. Yasumoto S. Wada K. Yamamoto T. Kishimoto (2000) ArticleTitleAntitumor effects of scutellariae radix and its componets baicalein, baicalin, and wogonin on bladder cancer cell lines Urology 55 951–955
C. Zhongli H. Yongke W. Jilan (1996) ArticleTitleStudy of baicalin scavenging hydroxyethyl peroxyl radicals by radiolysis of aerated ethanol-baicalin system Radiat. Phys. Chem. 47 869–871
E. Ciesielska A. Gwardys D. Metodiewa (2002) ArticleTitleAnticancer, antiradical and antioxidative actions of novel Antoksyd S and its major components, baicalin and baicalein Anticancer Res. 22 2885–2891
Z. Gao K. Huang X. Yang H. Xu (1999) ArticleTitleFree radical scavenging and antioxidant activities of flavonoids extracted from the radix of scutellaria baicalensis georgi Bichim. Biophys. Acta. 1472 643–650
I. X. Liu D. G. Durham R. M. Richards (2000) ArticleTitleBaicalin synergy with beta-lactam antibiotics against methicillin-resistant Staphylococcus aureus and other beta-lactam-resistant strains of S. aureus J. Pharm. Pharmacol. 52 361–366
B. Q. Li T. Fu W. H. Gong N. Dunlop H. Kung Y. Yan J. Kang J. M. Wang (2000) ArticleTitleThe flavonoid baicalin exhibits anti-inflammatory activity by binding to chemokines Immunopharmacology 49 295–306
T. C. Chou L. P. Chang C. Y. Li C. S. Wong S. P. Yang (2003) ArticleTitleThe anti-inflammatory and analgesic effects of baicalin in carrageenan-evoked thermal hyperalgesia Anesth. Analg. 97 1724–1729
Y. C. Shen W. F. Chiou Y. C. Chou C. F. Chen (2003) ArticleTitleMechanisms in mediating the anti-inflammatory effects of baicalin in human leukocytes Eur. J. Pharmacol. 465 171–181
Acknowledgments
This study was supported by CUHK Direct Grants (CUHK 2040830 and CUHK 2041012).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zhang, L., Lin, G., Chang, Q. et al. Role of Intestinal First-Pass Metabolism of Baicalein in its Absorption Process. Pharm Res 22, 1050–1058 (2005). https://doi.org/10.1007/s11095-005-5303-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11095-005-5303-7